Empowering start-ups from a venturing perspective

FIT has invested in several companies during last four years in sectors as medical device, pharmaceutical business, IT and industry (electronics and industrial control).

All the selected companies we have invested were in start-up phase from a venturing perspective in that either their products have already been developed or entered in “preclinical” phase in BIO-related opportunities

azure 200

New technologies for drugs and biomaterials stabilization

irisbond 200

Computer control technology by eye movement

nub3D 200

3D scanning technology that uses structured white light

palobiofarma

Drugs to improve people’s life quality suffering from neurodegenerative and respiratory diseases

signadyne 200

Test, measurement and control electronic equipment

This is a title

This is Photoshop’s version of Lorem Ipsum. Proin gravida nibh vel velit auctor aliquet.
Aenean sollicitudin, lorem quis bibendum auctor, nisi elit consequat ipsum, nec sagittis sem nibh id elit.

Duis sed odio sit amet nibh vulputate cursus a sit amet mauris. Morbi accumsan ipsum velit. Nam nec tellus a odio tincidunt auctor a ornare odio. Sed non mauris vitae erat consequat auctor eu in elit.